Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
- PMID: 32948978
- PMCID: PMC7500251
- DOI: 10.1007/s40120-020-00210-7
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
Abstract
ATTR amyloidosis is caused by systemic deposition of transthyretin (TTR) and comprises ATTRwt (wt for wild-type) amyloidosis, ATTRv (v for variant) amyloidosis, and acquired ATTR amyloidosis after domino liver transplantation. ATTRwt amyloidosis has classically been regarded as cardiomyopathy found in the elderly, whereas carpal tunnel syndrome has also become a major initial manifestation. The phenotypes of ATTRv amyloidosis are diverse and include neuropathy, cardiomyopathy, and oculoleptomeningeal involvement as the predominant features, depending on the mutation and age of onset. In addition to variant TTR, the deposition of wild-type TTR plays a significant role, even in patients with ATTRv amyloidosis. The formation of amyloid fibrils tends to occur in association with the basement membrane. The thickening or reduplication of the basement membrane surrounding endoneurial microvessels, which is similar to diabetic neuropathy, is observed in ATTRv amyloidosis, suggesting that common mechanisms, such as an accumulation of advanced glycation end products, may participate in the disease process. In addition to direct damage caused by amyloid fibrils, recent studies have suggested that the toxicity of nonfibrillar TTRs, such as TTR oligomers, participates in the process of tissue damage. Although liver transplantation has been performed for patients with ATTRv amyloidosis since 1990, late-onset patients were not eligible for this treatment. However, as the efficacy of orally administered tafamidis and diflunisal, which stabilize TTR tetramers, was suggested in the early 2010s, such late-onset patients have also become targets for disease-modifying therapies. Additionally, recent studies of small interfering RNA (patisiran) and antisense oligonucleotide (inotersen) therapies have demonstrated the efficacy of these gene-silencing agents. A strategy for monitoring patients that enables the choice of an appropriate treatment from comprehensive and long-term viewpoints should be established. As many patients with ATTR amyloidosis are aged and have heart failure, they are at increased risk of aggravation if they are infected by SARS-CoV2. The optimal interval of evaluation should also be considered, particularly in this COVID-19 era.
Keywords: Angiopathy; Cardiac amyloidosis; Electron microscopy; Microangiopathy; Pathogenesis; Pathology; Protein misfolding disease; Schwann cell; Therapy; Ultrastructure.
Figures





Similar articles
-
Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.Biomedicines. 2019 Feb 5;7(1):11. doi: 10.3390/biomedicines7010011. Biomedicines. 2019. PMID: 30764529 Free PMC article. Review.
-
Multidisciplinary Approaches for Transthyretin Amyloidosis.Cardiol Ther. 2021 Dec;10(2):289-311. doi: 10.1007/s40119-021-00222-w. Epub 2021 Jun 4. Cardiol Ther. 2021. PMID: 34089151 Free PMC article. Review.
-
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.Neurol Ther. 2023 Feb;12(1):267-287. doi: 10.1007/s40120-022-00414-z. Epub 2022 Dec 16. Neurol Ther. 2023. PMID: 36525140 Free PMC article.
-
Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):1036-43. doi: 10.1136/jnnp-2014-308724. Epub 2015 Jan 20. J Neurol Neurosurg Psychiatry. 2015. PMID: 25604431 Review.
-
A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis.J Cardiovasc Pharmacol. 2021 May 1;77(5):544-548. doi: 10.1097/FJC.0000000000001004. J Cardiovasc Pharmacol. 2021. PMID: 33657048 Review.
Cited by
-
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy.Orphanet J Rare Dis. 2021 Apr 7;16(1):163. doi: 10.1186/s13023-021-01812-6. Orphanet J Rare Dis. 2021. PMID: 33827635 Free PMC article.
-
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.J Clin Med. 2021 May 1;10(9):1954. doi: 10.3390/jcm10091954. J Clin Med. 2021. PMID: 34062949 Free PMC article. Review.
-
Anticoagulation in Atrial Fibrillation Associated With Cardiac Amyloidosis: A Narrative Review.Cureus. 2024 Jun 3;16(6):e61557. doi: 10.7759/cureus.61557. eCollection 2024 Jun. Cureus. 2024. PMID: 38962633 Free PMC article. Review.
-
From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic cardiomyopathies.Front Physiol. 2023 Jul 19;14:1237101. doi: 10.3389/fphys.2023.1237101. eCollection 2023. Front Physiol. 2023. PMID: 37538375 Free PMC article. Review.
-
Modulation of the Mechanisms Driving Transthyretin Amyloidosis.Front Mol Neurosci. 2020 Dec 11;13:592644. doi: 10.3389/fnmol.2020.592644. eCollection 2020. Front Mol Neurosci. 2020. PMID: 33362465 Free PMC article. Review.
References
-
- Adams D, Koike H, Slama M, Coelho T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 2019;15:387–404. - PubMed
-
- Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2018;25:215–219. - PubMed
-
- Stangou AJ, Heaton ND, Rela M, Pepys MB, Hawkins PN, Williams R. Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy. Transplantation. 1998;65:1496–1498. - PubMed
-
- Koike H, Hashimoto R, Tomita M, et al. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid. 2011;18:53–62. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous